全文获取类型
收费全文 | 271篇 |
免费 | 20篇 |
专业分类
儿科学 | 6篇 |
妇产科学 | 5篇 |
基础医学 | 20篇 |
临床医学 | 10篇 |
内科学 | 136篇 |
神经病学 | 3篇 |
外科学 | 5篇 |
综合类 | 2篇 |
预防医学 | 2篇 |
眼科学 | 93篇 |
药学 | 1篇 |
中国医学 | 1篇 |
肿瘤学 | 7篇 |
出版年
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 6篇 |
2019年 | 8篇 |
2018年 | 6篇 |
2017年 | 5篇 |
2016年 | 2篇 |
2015年 | 2篇 |
2014年 | 5篇 |
2013年 | 11篇 |
2012年 | 30篇 |
2011年 | 31篇 |
2010年 | 26篇 |
2009年 | 24篇 |
2008年 | 14篇 |
2007年 | 18篇 |
2006年 | 14篇 |
2005年 | 13篇 |
2004年 | 6篇 |
2003年 | 5篇 |
2002年 | 15篇 |
2001年 | 12篇 |
2000年 | 1篇 |
1999年 | 6篇 |
1998年 | 2篇 |
1996年 | 3篇 |
1995年 | 1篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1986年 | 6篇 |
1985年 | 1篇 |
1984年 | 2篇 |
排序方式: 共有291条查询结果,搜索用时 15 毫秒
1.
J Pe'er 《American journal of ophthalmology》1988,106(6):742-743
2.
Molecular determinants of human uveal melanoma invasion and metastasis 总被引:19,自引:0,他引:19
Seftor EA Meltzer PS Kirschmann DA Pe'er J Maniotis AJ Trent JM Folberg R Hendrix MJ 《Clinical & experimental metastasis》2002,19(3):233-246
The molecular analysis of cancer has benefited tremendously from the sequencing of the human genome integrated with the science
of bioinformatics. Microarray analysis technology has the potential to classify tumors based on the differential expression
of genes. In the current study, a collaborative, multidisciplinary approach was utilized to study the molecular determinants
of human uveal melanoma invasion and metastasis. Uveal melanoma is considered the most common primary intraocular cancer in
adults, resulting in the death of approximately 50% of patients affected. Unfortunately, at the time of diagnosis, many patients
already harbor microscopic metastases, thus underscoring a critical need to identify prognostic markers indicative of metastatic
potential. The investigative strategy consisted of isolating highly invasive vs. poorly invasive uveal melanoma cells from
a heterogeneous tumor derived from cells that had metastasized from the eye to the liver. The heterogeneous tissue explant
MUM-2 led to the derivation of two clonal cell lines: MUM-2B and MUM-2C. Further morphological and functional analyses revealed
that the MUM-2B cells were epithelioid, interconverted (expressing mesenchymal and epithelial phenotypes) highly invasive,
and demonstrated vasculogenic mimicry. The MUM-2C cells were spindle-like, expressed only a vimentin mesenchymal phenotype,
poorly invasive, and were incapable of vasculogenic mimicry. The molecular analysis of the MUM-2B vs. the MUM-2C clones resulted
in the differential expression of 210 known genes. Overall, the molecular signature of the MUM-2B cells resembled that of
multiple phenotypes – similar to a pluripotent, embryonic-like genotype. Validation of select genes that were upregulated
and down-regulated was conducted by semiquantitative RT-PCR measurement. This study provides a molecular profile that will
hopefully lead to the development of new molecular targets for therapeutic intervention and possible diagnostic markers to
predict the clinical outcome of patients with uveal melanoma.
This revised version was published online in July 2006 with corrections to the Cover Date. 相似文献
3.
4.
Charan Yerasi Toby Rogers Brian J. Forrestal Brian C. Case Jaffar M. Khan Itsik Ben-Dor Lowell F. Satler Hector M. Garcia-Garcia Jeffrey E. Cohen Hiroto Kitahara Christian Shults Ron Waksman 《JACC: Cardiovascular Interventions》2021,14(11):1169-1180
Transcatheter aortic valve replacement (TAVR) is approved for all patient risk profiles and is an option for all patients irrespective of age. However, patients enrolled in the low- and intermediate-risk trials were in their 70s, and those in the high-risk trials were in their 80s. TAVR has never been systematically tested in young (<65 years), low-risk patients. Unanswered questions remain, including the safety and effectiveness of TAVR in patients with bicuspid aortic valves; future coronary access; durability of transcatheter heart valves; technical considerations for surgical transcatheter heart valve explantation; management of concomitant conditions such as aortopathy, mitral valve disease, and coronary artery disease; and the safety and feasibility of future TAVR-in-TAVR. The authors predict that balancing these questions with patients’ clear preference for less invasive treatment will become common. In this paper, the authors consider each of these questions and discuss risks and benefits of theoretical treatment strategies in the lifetime management of young patients with severe aortic stenosis. 相似文献
5.
6.
7.
Ben-Dor I Maluenda G Iyasu GD Laynez-Carnicero A Hauville C Torguson R Okubagzi P Xue Z Goldstein SA Lindsay J Satler LF Pichard AD Waksman R 《The American journal of cardiology》2012,109(7):1031-1037
Left ventricular systolic dysfunction in patients with severe aortic stenosis (AS) is associated with poor outcome. This analysis was designed primarily to describe the clinical course of a large series of consecutive patients with severe AS and low ejection fraction (EF) (<40%) who, because of high surgical risk, were referred for transcatheter aortic valve implantation consideration. A cohort of 270 patients with severe AS and low EF (<40%) who were referred to participate in a clinical trial of transcatheter aortic valve implantation was studied. Clinical, hemodynamic, and periprocedural complications and follow-up mortality data were collected and compared between patients with low mean transvalvular gradients (≤40 mm Hg, n = 170 [63%]) and high transvalvular gradients (>40 mm Hg, n = 100 [37%]). Patients with low gradients were younger (mean age 79.8 ± 9.1 vs 83.8 ± 7.7 years, p <0.001) and had higher incidences of coronary artery disease and renal failure. Mean aortic valve area was larger (0.73 ± 0.23 vs 0.53 ± 0.18 cm(2), p <0.001), while mean EF (26.4 ± 6.9% vs 30.5% ± 6.6%, p <0.001), cardiac output (3.7 ± 1.1 vs 4.1 ± 1.3 L/min, p = 0.04), and cardiac index (1.9 ± 0.5 vs 2.1 ± 0.6 L/min/m(2), p = 0.04) were lower in patients with lower gradients compared to those with higher gradients, respectively. Mortality was higher in patients with low gradients (53.8%) at a mean follow-up of 151 days compared to those with high gradients (41%) at a mean follow-up of 256 days (p = 0.01). In conclusion, patients with severe AS and low EF with low transvalvular gradients are at higher risk for worse outcomes compared to patients with high transvalvular gradients. Surgery or transcatheter aortic valve implantation treatment and high baseline transvalvular gradient are associated with EF improvement. 相似文献
8.
Waksman R Barbash IM Dvir D Torguson R Ben-Dor I Maluenda G Xue Z Satler LF Suddath WO Kent KM Pichard AD 《The American journal of cardiology》2012,109(9):1288-1294
Data from randomized clinical trials have shown the safety and efficacy of the XIENCE V in selected populations. However, limited data are available comparing the XIENCE V to the first-generation CYPHER sirolimus-eluting stent. This study aimed to assess the long-term safety and clinical efficacy of the XIENCE V everolimus-eluting stent compared to first-generation stents in an unselected patient population. This retrospective analysis included 6,069 patients treated with CYPHER, TAXUS, and XIENCE stents from 2003 to 2009 at our institution. The patients were followed up for ≥1 year after the index procedure. The baseline characteristics were generally comparable among the 3 groups, with the exception of a significantly greater prevalence of diabetes mellitus, systemic hypertension, and a history of angioplasty and coronary bypass surgery among the XIENCE patients. The XIENCE patients also had a twofold greater rate of type C lesions. One-year follow-up data were available for 82% of the patients. The 1-year major adverse cardiovascular events rate was 9.3% for the XIENCE stent versus 9.8% for the CYPHER stent and 11.5% for the TAXUS stent (p = 0.11). Mortality was lower in the XIENCE group than in the CYPHER and TAXUS groups (3.6% vs 4.9% vs 7.2%, respectively, p <0.001), and target lesion revascularization was similar (5.9% vs 5.2% vs 5.6%, respectively; p = 0.34). Stent thrombosis was lower in the XIENCE patients (0.2% vs 1.2% vs 0.7%, p = 0.007). In conclusion, in a contemporary United States clinical practice with an unselected patient population, use of the XIENCE V stent was associated with an improved safety profile and reduction of all-cause mortality and stent thrombosis compared to first-generation drug-eluting stents. The XIENCE V failed to demonstrate superiority for overall major adverse cardiovascular events, Q-wave myocardial infarction, and revascularization rates. 相似文献
9.
Romaguera R Wakabayashi K Laynez-Carnicero A Sardi G Maluenda G Ben-Dor I Torguson R Kent KM Satler LF Suddath WO Lindsay J Pichard AD Waksman R 《The American journal of cardiology》2012,109(1):75-81
Vascular complications (VCs) occur in 3% to 8% of percutaneous coronary interventions (PCIs). However, only a portion of patients who experience VCs bleed significantly. The aim of this study was to assess the covariates associated with the amount of blood loss in patients experiencing postprocedural VCs as well as the effect of the degree of blood loss on long-term mortality. Overall, 7,718 unselected patients who underwent PCI through femoral access were evaluated. Those experiencing VCs were identified and stratified with regard to the degree of hematocrit (HCT) decrease after the procedure. In total, 444 patients (5.8%) had VCs. Compared to those without VCs, patients with VCs were older and had more extensive co-morbidities. Severe blood loss was most frequent in those who had vascular perforation requiring surgical repair or in those who had retroperitoneal bleeding. Overall, <25% of patients with hematoma had severe blood loss. The raw 1-year mortality was doubled in patients with minimal or moderate HCT decrease and was tripled in those with severe decreases in HCT. Similarly, the rate of definite stent thrombosis was tripled in patients with VCs and moderate or severe decreases in HCT. After adjustment, only patients with VCs and the greater HCT decreases had an increased risk for death at 1 year (hazard ratio 1.80, 95% confidence interval 1.03 to 3.14). Independent predictors of severe HCT decrease included age, female gender, glycoprotein IIb/IIIa inhibitor use, and activated clotting time peak. Bivalirudin and closure devices were independently associated with less frequent severe HCT decrease. In conclusion, VCs do not entail an increased risk for death at 1 year unless associated with severe blood loss. The use of bivalirudin and closure devices seems to reduce the risk for such complications. 相似文献
10.
Gabriel Maluenda MD Lavinia Mitulescu MD Itsik Ben‐Dor MD Michael A. Gaglia Jr. MD MSc Gaby Weissman MD Rebecca Torguson MPH Lowell F. Satler MD Augusto D. Pichard MD Nelson L. Bernardo MD Ron Waksman MD 《Catheterization and cardiovascular interventions》2012,80(1):29-36
Background : Retroperitoneal hemorrhage (RPH) is a serious but infrequent complication of percutaneous coronary intervention (PCI). This study aimed to describe the clinical outcomes of patients who developed RPH following PCI in the current practice era, with particular focus on treatment strategies and the related prognostic value of abdominal/pelvic computed tomography (CT). Methods : Among 20,904 patients undergoing PCI, we identified 93 RPH (0.45%) confirmed by CT or by unequivocal surgical findings. We identified three groups with RPH for comparison: patients who developed refractory shock (systolic blood pressure <80 mm Hg for ≥30 min despite fluids and vasopressors, n = 16 [17.2%]); patients with transient hypotension (<30 min, n = 34 [36.6%]); and patients without hypotension (n = 43 [46.2%]). The primary endpoint was a composite of in‐hospital mortality, myocardial infarction, and cerebral vascular accident (CVA). Results : Baseline clinical, angiographic, and procedural characteristics were similar among the three groups. Patients who developed refractory shock had significantly more bleeding quantified by abdominal/pelvic CT (P < 0.001), had a higher rate and amount of red blood cell transfusion (P < 0.001), and were managed invasively more frequently (68.7%) than the rest of the population. The primary endpoint trended higher in patients presenting with refractory shock; however, this difference was not statistically significant. The volume of bleeding quantified by CT and the timing of imaging diagnosis did not correlate with the primary endpoint. Red blood cell transfusion, but not clopidogrel discontinuation, was associated with the primary endpoint. Conclusions : RPH remains as a serious complication of PCI and is associated with high rates of mortality and morbidity independently of the therapeutic strategy. In patients who were hemodynamically stable, RPH volume as quantified by non‐contrast abdominal/pelvic CT did not contribute to prognosis. © 2011 Wiley Periodicals, Inc. 相似文献